GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHA:600771)
14.91
+0.14 (0.95%)
Jul 31, 2026, 3:00 PM CST
SHA:600771 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 7,298 | 8,801 | 9,232 | 13,211 | 13,618 | 21,077 | |
Market Cap Growth | -31.64% | -4.67% | -30.12% | -2.98% | -35.39% | 188.41% |
Enterprise Value | 6,941 | 8,573 | 9,159 | 13,293 | 13,985 | 21,315 |
Last Close Price | 14.91 | 17.98 | 18.86 | 26.99 | 27.82 | 43.06 |
PE Ratio | 109.24 | 139.60 | 124.00 | 146.67 | - | - |
Forward PE | - | 48.48 | 48.48 | 48.48 | 48.48 | 48.48 |
PS Ratio | 5.07 | 6.43 | 7.56 | 10.29 | 12.04 | 24.67 |
PB Ratio | 4.24 | 5.32 | 5.80 | 8.76 | 9.57 | 9.85 |
P/TBV Ratio | 4.52 | 5.69 | 6.26 | 9.42 | 10.35 | 10.52 |
P/FCF Ratio | 42.99 | 45.92 | 89.10 | 62.03 | 55.64 | 333.64 |
P/OCF Ratio | 41.51 | 44.47 | 82.14 | 61.31 | 53.73 | 259.04 |
EV/Sales Ratio | 4.82 | 6.26 | 7.50 | 10.35 | 12.37 | 24.95 |
EV/EBITDA Ratio | 40.17 | 54.24 | 67.41 | 87.19 | - | - |
EV/EBIT Ratio | 53.13 | 70.05 | 100.94 | 117.45 | - | - |
EV/FCF Ratio | 40.88 | 44.74 | 88.40 | 62.41 | 57.14 | 337.40 |
Debt / Equity Ratio | 0.02 | 0.03 | 0.04 | 0.19 | 0.30 | 0.15 |
Debt / EBITDA Ratio | 0.18 | 0.25 | 0.43 | 1.83 | - | - |
Debt / FCF Ratio | 0.18 | 0.22 | 0.60 | 1.37 | 1.77 | 5.19 |
Net Debt / Equity Ratio | -0.22 | -0.15 | -0.03 | 0.02 | 0.13 | 0.09 |
Net Debt / EBITDA Ratio | -2.32 | -1.61 | -0.40 | 0.21 | -0.99 | -0.56 |
Net Debt / FCF Ratio | -2.24 | -1.33 | -0.53 | 0.15 | 0.76 | 2.89 |
Asset Turnover | 0.58 | 0.58 | 0.50 | 0.48 | 0.39 | 0.25 |
Inventory Turnover | 0.67 | 0.59 | 0.49 | 0.71 | 1.05 | 0.93 |
Quick Ratio | 1.29 | 1.11 | 0.89 | 1.05 | 1.26 | 2.00 |
Current Ratio | 2.20 | 2.15 | 2.16 | 1.61 | 1.67 | 2.43 |
Return on Equity (ROE) | 4.00% | 3.93% | 5.40% | 6.33% | -14.76% | -14.42% |
Return on Assets (ROA) | 3.30% | 3.25% | 2.31% | 2.66% | -4.88% | -6.57% |
Return on Invested Capital (ROIC) | 5.76% | 5.16% | 5.90% | 6.65% | -11.53% | -15.32% |
Return on Capital Employed (ROCE) | 7.40% | 7.20% | 5.50% | 7.10% | -13.80% | -16.30% |
Earnings Yield | 0.91% | 0.72% | 0.81% | 0.68% | -1.84% | -1.50% |
FCF Yield | 2.33% | 2.18% | 1.12% | 1.61% | 1.80% | 0.30% |
Payout Ratio | 1.80% | 1.89% | 5.30% | 15.91% | - | - |
Buyback Yield / Dilution | 15.32% | 15.32% | -14.44% | -2.08% | 0.79% | -8.08% |